February 3, 2026
HemostOD awarded CHF 2 million Innosuisse grant
HemostOD has been awarded a CHF 2 million grant from Innosuisse to advance its universal platelet manufacturing platform.
Official Press Release
View the complete press release document
HemostOD awarded CHF 2 million Innosuisse grant
HemostOD has been awarded a CHF 2 million grant from Innosuisse, the Swiss Innovation Agency, to advance its universal platelet manufacturing platform.
This significant funding will support the company's research and development efforts in bringing engineered platelets to patients in need.